Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-22 @ 10:55 PM
Study NCT ID:
NCT02761057
Status:
COMPLETED
Last Update Posted:
2025-01-13
First Post:
2016-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Locally Advanced Papillary Renal Cell Carcinoma | View |
| None | Metastatic Papillary Renal Cell Carcinoma | View |
| None | Stage III Renal Cell Cancer AJCC v7 | View |
| None | Stage IV Renal Cell Cancer AJCC v7 | View |
| None | Type 1 Papillary Renal Cell Carcinoma | View |
| None | Type 2 Papillary Renal Cell Carcinoma | View |
| None | Unresectable Renal Cell Carcinoma | View |
Keywords: